AVIR
Atea Pharmaceuticals Inc
NASDAQ: AVIR · HEALTHCARE · BIOTECHNOLOGY
$5.51
+1.47% today
Updated 2026-04-30
Market cap
$435.81M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-1.94
Dividend yield
—
52W range
$2 – $6
Volume
0.5M
Atea Pharmaceuticals Inc (AVIR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.91M | $-12.81M | $296.73M | $-87.00M | $-120.98M | $-85.39M | $-135.50M | $-132.03M |
| Capital expenditures | $12000.00 | $2000.00 | $26000.00 | $4000.00 | $1.94M | $0.00 | $0.00 | $0.00 |
| Depreciation | $17000.00 | $17000.00 | $19000.00 | $29000.00 | $260000.00 | $416000.00 | $416000.00 | — |
| Stock-based comp | $414000.00 | $624000.00 | $7.46M | $39.62M | $46.72M | $49.43M | $51.77M | $20.72M |
| Free cash flow | $-7.92M | $-12.82M | $296.71M | $-87.01M | $-122.92M | $-85.39M | $-135.50M | $-132.03M |
| Investing cash flow | $-12000.00 | $-2000.00 | $-26000.00 | $-4000.00 | $-455.41M | $40.30M | $56.10M | — |
| Financing cash flow | $27.48M | $-15000.00 | $531.75M | $1.47M | $370000.00 | $257000.00 | $267000.00 | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $828.46M | $-85.54M | — | — | — | — |